최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한방비만학회지 = Journal of Korean Medicine for Obesity Research, v.20 no.1, 2020년, pp.31 - 39
윤상훈 (청연중앙연구소) , 이은지 (청연중앙연구소) , 조현정 (청연한방병원) , 한예지 (의료법인해인의료재단 동신한방병원) , 김현호 (청연중앙연구소) , 윤영희 (씨와이기업부설연구소) , 최예용 (씨와이기업부설연구소) , 박종승 (청연중앙연구소) , 임정태 (청연중앙연구소)
Objectives: Obesity is becoming more popular disease worldwide. Because of the side effects of conventional obesity treatment modality, herbal medicine treatment is becoming more preferred. Gambihwan which including Ephedra sinica Staph is widely used in traditional Korean Medicine practice for obes...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
비만이란? | 비만은 과도하거나 비정상적인 지방이 체내에 축적되는 것으로1), 1980년부터 2014년까지 비만의 유병률은 전 세계적으로 2배 이상 증가하고 있다2). 이러한 비만은 생존기간을 줄일 뿐 아니라3) 많은 장기에 영향을 끼쳐 당뇨, 신장질환, 심장질환의 발생을 증가시킨다4,5). | |
본 연구에서 감비환을 제조한 시설은? | 1). 모든 조제 공정은 보건복지부에서 일반한약조제 원외탕전실 인증을 부여받은 청연한방병원 원외탕전실에서 이루어졌다. | |
비만치료에서 대표적으로 처방되는 한약재는? | 비만치료에서 한약은 널리 활용되고 있으며, 그중 대표적으로 처방되는 약재는 마황(麻黃, Ephedra sinica)이 다13,14). 마황은 에페드린(ephedrine)을 주요 성분으로 하는 약제로 식욕 저하를 유발하고 체내의 신진대사를 증진시켜 체중을 감소시키는 효과가 있다고 알려졌다15). |
Anuurad E, Shiwaku K, Nogi A, Kitajima K, Enkhmaa B, Shimono K, et al. The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health. 2003 ; 45 : 335-43.
World Health Organization. Global status report on noncommunicable diseases 2014. Geneva : WHO Press. 2014.
Prospective Studies Collaboration; Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet Lond Engl. 2009 ; 373 : 1083-96.
Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995 ; 332 : 621-8.
Greenway FL. Physiological adaptations to weight loss and factors favouring weight regain. Int J Obes. 2015 ; 39(8) : 1188-96.
Bray GA, Fruhbeck G, Ryan DH, Wilding JPH. Management of obesity. The Lancet. 2016 ; 387 : 1947-56.
Tak YJ, Lee SY. Anti-obesity drugs: long-term efficacy and safety: an updated review. World J Mens Health. 2020 ; 38 : e14.
Shin C, Park J, Park JJ, Seo SW, Shim JI. Assessment of clinical safety and efficacy for weight loss supplements (Garcinia cambogia extract, Irvingia gabonesis seed extract) in humans. Seoul Repub Korea Natl Evid-Based Healthc Collab Agency. 2017 ; 1-146.
Semwal RB, Semwal DK, Vermaak I, Viljoen A. A comprehensive scientific overview of Garcinia cambogia. Fitoterapia. 2015 ; 102 : 134-48.
Jones FJ, Andrews AH. Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq. Am J Gastroenterol. 2007 ; 102 : 2357-8.
Actis GC, Bugianesi E, Ottobrelli A, Rizzetto M. Fatal liver failure following food supplements during chronic treatment with montelukast. Dig Liver Dis. 2007 ; 39 : 953-5.
Melendez-Rosado J, Snipelisky D, Matcha G, Stancampiano F. Acute hepatitis induced by pure Garcinia cambogia. J Clin Gastroenterol. 2015 ; 49 : 449-50.
Song YK, Lim HH. Clinical application of Ma Huang in the obesity treatment. J Soc Korean Med Obes Res. 2007 ; 7 : 1-7.
Song MY, Kim HJ, Lee MJ. The safety guidelines for use of Ma-huang in obesity treatment. J Korean Orient Assoc Study Obes. 2006 ; 6 : 17-27.
Astrup A, Breum L, Toubro S, Hein P, Quaade F. Ephedrine and weight loss. Int J Obes Relat Metab Disord J Int Assoc Study Obes. 1992 ; 16 : 715.
Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord J Int Assoc Study Obes. 2002 ; 26 : 593-604.
Kim H, Han C-H, Lee E-J, Song Y-K, Shin B-C, Kim Y-K. A clinical practice guideline for Ma-huang (Ephedra sinica) prescription in obesity. J Soc Korean Med Obes Res. 2007 ; 7 : 27-37.
National Cancer Institute. Grading: General Characteristics of the CTCAE (Common Terminology Criteria for Adverse Events) Grading (Severity) Scale. 2012.
World Health Organization (WHO)-Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment. 2012.
Kim YJ, Choi MS, Park YB, Kim SR, Lee MK, Jung UJ. Garcinia cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. World J Gastroenterol. 2013 ; 19 : 4689-701.
Zheng E, Navarro V. Liver injury due to herbal and dietary supplements: a review of individual ingredients. Clin Liver Dis. 2016 ; 7 : 80-3.
Corey R, Werner K T, S inger A, M oss A, S mith M, Noelting J, et al. Acute liver failure associated with Garcinia cambogia use. Ann Hepatol. 2016 ; 15 : 123-6.
Katial RK, Stelzle RC, Bonner MW, Marino M, Cantilena LR, Smith LJ. A drug interaction between zafirlukast and theophylline. Arch Intern Med. 1998 ; 158 : 1713-5.
Walsky RL, Obach RS, Gaman EA, Gleeson JPR, Proctor WR. Selective inhibition of human cytochrome P4502C8 by montelukast. Drug Metab Dispos Biol Fate Chem. 2005 ; 33 : 413-8.
Saito M, Hirata-Koizumi M, Matsumoto M, Urano T, Hasegawa R. Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies. Drug Saf. 2005 ; 28 : 677-94.
Rotblatt M, Ziment I. Evidence-based herbal medicine. Philadelphia, PA : Hanley & Belfus. 2001.
Lee MK, Cheng BWH, Che CT, Hsieh DPH. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol Sci. 2000 ; 56 : 424-30.
Shannon JR, Gottesdiener K, Jordan J, Chen K, Flattery S, Larson PJ, et al. Acute effect of ephedrine on 24-h energy balance. Clin Sci. 1999 ; 96 : 483-91.
hite LM, Gardner SF, Gurley BJ, Marx MA, Wang P-L, Estes M. Pharmacokinetics and cardiovascular effects of Ma-Huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol. 1997 ; 37 : 116-22.
Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003 ; 289 : 1537-45.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000 ; 343 : 1833-8.
Food and Drug Administration, HHS. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule. Fed Regist. 2004 ; 69 : 6787-854.
Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol. 2001 ; 96 : 1654-5.
Meyer zum Buschenfelde KH, Lohse AW. Autoimmune hepatitis. N Engl J Med. 1995 ; 333 : 1004-5.
Lee E, Yoon S-H, Kim H, Kim YD, Leem J, Park J. Ephedrae Herba in combination with herbal medicine (Zhizichi decoction and Phellodendri Cortex) for weight reduction: a case series. Integr Med Res. 2020 ; 9 : 100408.
Jo DH, Lee S, Lee JD. Effects of Gambisan in overweight adults and adults with obesity: a retrospective chart review. Medicine (Baltimore). 2019 ; 98 : e18060.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.